...All right. Hello, everyone. Welcome to the next session here at the Barclays TMT Conference. I'm Steven Valiquette, the health care technology analyst here at Barclays. Next company up here is GoodRx, which I co-cover with Ross Sandler. With us from the management are Doug Hirsch, who is the Co-Founder and Co-CEO; as well as Karsten Voermann, the company's CFO. This will be a fireside chat, where Ross and I will take turns asking a few questions at a time. But before we do that, I'm going to turn it over to Whitney Notaro from Investor Relations at GoodRx just to read some disclosures. So Whitney, over to you. Whitney Notaro ...